FMP
May 3, 2024 6:05 PM - Davit Kirakosyan
Image credit: FMP
Amgen (NASDAQ:AMGN) announced on Thursday that it will discontinue its experimental weight-loss pill to focus on its injectable drug, MariTide, and other obesity-related developments. Jay Bradner, Amgen’s Chief Scientific Officer, explained during an earnings call that the company has decided to cease further development of the oral drug based on its performance and instead channel resources into MariTide and other preclinical projects.
Following this announcement, Amgen's shares jumped over 12% intra-day today. The injectable treatment, MariTide, is currently in a mid-stage trial for obese or overweight adults who do not have diabetes. Amgen plans to release initial data from this trial later this year, and Bradner expressed satisfaction with the preliminary results.
In addition, Amgen is collaborating with regulatory agencies to plan a late-stage trial for MariTide and has also announced a second-stage trial aimed at evaluating the drug's effectiveness in treating diabetes.
May 27, 2024 3:30 PM - Rajnish Katharotiya
In the ever-evolving world of technology, certain sectors have consistently demonstrated exceptional growth and innovation. The graphics processing units (GPUs) industry is one such sector, offering investors a golden opportunity for potentially high returns. In this blog, we'll delve into why inves...
Jun 6, 2024 2:47 AM - Parth Sanghvi
ROE vs. ROA: Which Metric is More Important for Investors? When evaluating a company's financial performance, investors often rely on various metrics to gauge profitability and efficiency. Two commonly discussed metrics are Return on Equity (ROE) and Return on Assets (ROA). Understanding the diff...
Jun 6, 2024 2:57 AM - Parth Sanghvi
When it comes to valuing an investment or a business, two of the most commonly used methods are Discounted Cash Flow (DCF) and Net Present Value (NPV). Both methods are essential tools in finance, but they serve slightly different purposes and are used in different contexts. This guide will explore ...